CN Patent

CN108283013B — 骨髓纤维症的诊断和预后辅助及治疗效果监测方法及装置

Assigned to Sysmex Corp · Expires 2020-10-30 · 6y expired

What this patent protects

本发明涉及辅助骨髓纤维症(MF)的状态的诊断的方法、辅助MF的预后预测的方法、及MF的治疗效果的监测方法。另外，本发明涉及用于执行这些方法的装置。再者，本发明涉及骨髓纤维化状态的判断用标志物。

USPTO Abstract

本发明涉及辅助骨髓纤维症(MF)的状态的诊断的方法、辅助MF的预后预测的方法、及MF的治疗效果的监测方法。另外，本发明涉及用于执行这些方法的装置。再者，本发明涉及骨髓纤维化状态的判断用标志物。

Drugs covered by this patent

Patent Metadata

Patent number
CN108283013B
Jurisdiction
CN
Classification
—
Expires
2020-10-30
Drug substance claim
No
Drug product claim
No
Assignee
Sysmex Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.